Xiao XH - Search Results

1

Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma.

Jin M, Jiang ZQ, Qin JH, Qin HX, Jiang KW, Ya HX, Gu J, Gui MR, Li YH, Xu LK, Fu HX, Xiao XH, Li SQ. Jin M, et al. Among authors: xiao xh. J Hepatocell Carcinoma. 2024 Nov 25;11:2309-2320. doi: 10.2147/JHC.S485047. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39619601 Free PMC article.

2

Case report: Complete response after transcatheter arterial chemoembolization combined with donafenib plus tislelizumab therapy for hepatocellular carcinoma with main trunk portal vein tumor thrombus in a patient coinfected with HIV and HBV.

Xiao X, Fu H, Qin H, Xu L, Gu J, Zhang Z, Ya H, Jiang K, Jian Z, Li S. Xiao X, et al. Front Immunol. 2024 Jul 15;15:1422801. doi: 10.3389/fimmu.2024.1422801. eCollection 2024. Front Immunol. 2024. PMID: 39076997 Free PMC article.

3

Nomogram for predicting severe abdominal pain after initial conventional transarterial chemoembolisation for hepatocellular carcinoma: a retrospective study.

Qin H, Xiao X, Ya H, Li J, Liang F, Jin H, Liao L, Li Y, Qin J, Yu J, Gu J, Zhou C, Jin M, Miao Y, Li S. Qin H, et al. Sci Rep. 2023 Dec 16;13(1):22397. doi: 10.1038/s41598-023-49509-z. Sci Rep. 2023. PMID: 38104191 Free PMC article.

4

miR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma.

Wang L, Bo X, Zheng Q, Xiao X, Wu L, Li B. Wang L, et al. FEBS Lett. 2016 Dec;590(23):4252-4262. doi: 10.1002/1873-3468.12442. Epub 2016 Oct 21. FEBS Lett. 2016. PMID: 27714806 Free article.

5

Role of N6-Methyladenosine (m⁶A) Methylation Regulators in Hepatocellular Carcinoma.

Qu N, Bo X, Li B, Ma L, Wang F, Zheng Q, Xiao X, Huang F, Shi Y, Zhang X. Qu N, et al. Front Oncol. 2021 Oct 7;11:755206. doi: 10.3389/fonc.2021.755206. eCollection 2021. Front Oncol. 2021. PMID: 34692544 Free PMC article. Review.

6

Hypoxia-induced LncRNA DACT3-AS1 upregulates PKM2 to promote metastasis in hepatocellular carcinoma through the HDAC2/FOXA3 pathway.

Wang L, Li B, Bo X, Yi X, Xiao X, Zheng Q. Wang L, et al. Exp Mol Med. 2022 Jun;54(6):848-860. doi: 10.1038/s12276-022-00767-3. Epub 2022 Jun 28. Exp Mol Med. 2022. PMID: 35764883 Free PMC article.

7

Cell-Membrane-Coated Metal-Organic Framework Nanocarrier Combining Chemodynamic Therapy for the Inhibition of Hepatocellular Carcinoma Proliferation.

Xie H, Xiao X, Yi X, Huang K, Wang L. Xie H, et al. Pharmaceutics. 2024 May 5;16(5):619. doi: 10.3390/pharmaceutics16050619. Pharmaceutics. 2024. PMID: 38794281 Free PMC article.

8

Circ_0036412 affects the proliferation and cell cycle of hepatocellular carcinoma via hedgehog signaling pathway.

Wang L, Li B, Yi X, Xiao X, Zheng Q, Ma L. Wang L, et al. J Transl Med. 2022 Apr 5;20(1):154. doi: 10.1186/s12967-022-03305-x. J Transl Med. 2022. PMID: 35382824 Free PMC article.

9

Collagenous gastritis in a young Chinese woman: A case report.

Zheng QH, Hu J, Yi XY, Xiao XH, Zhou LN, Li B, Bo XT. Zheng QH, et al. Among authors: xiao xh. World J Gastroenterol. 2022 Nov 7;28(41):5993-6001. doi: 10.3748/wjg.v28.i41.5993. World J Gastroenterol. 2022. PMID: 36405104 Free PMC article.

10

Exosomal miR-628-5p from M1 polarized macrophages hinders m6A modification of circFUT8 to suppress hepatocellular carcinoma progression.

Wang L, Yi X, Xiao X, Zheng Q, Ma L, Li B. Wang L, et al. Cell Mol Biol Lett. 2022 Dec 6;27(1):106. doi: 10.1186/s11658-022-00406-9. Cell Mol Biol Lett. 2022. PMID: 36474147 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters